InMed Pharmaceuticals (INM) has released an update.
Confident Investing Starts Here:
- Easily unpack a company's performance with TipRanks' new KPI Data for smart investment decisions
- Receive undervalued, market resilient stocks right to your inbox with TipRanks' Smart Value Newsletter
InMed Pharmaceuticals has entered into a Standby Equity Purchase Agreement with Yorkville Advisors, allowing it to sell up to $10 million of its common shares over a 36-month period. This financial strategy provides InMed with flexibility to raise capital as needed, supporting the acceleration of its pharmaceutical programs.
For further insights into INM stock, check out TipRanks’ Stock Analysis page.
Trending Articles:
Looking for a trading platform? Check out TipRanks' Best Online Brokers , and find the ideal broker for your trades.
Report an Issue